Global /United States /Healthcare /Medical Devices /ABT
chevron_leftBack
Abbott Laboratories logo

Abbott Laboratories

ABT
NYSE: ABT Delayed
91.33USD -2.7%
As of 10 July 2026, Abbott Laboratories has a market cap of $159.07B USD, ranking #117 globally and #67 in the United States. It ranks #15 in the Healthcare sector, and #3 in the Medical Devices industry.
Global Rank
117
1d: 0
1w: -1
1m: -
Country Rank
67
1d: 0
1w: -1
1m: -
Sector Rank
15
1d: 0
1w: 0
1m: -
Industry Rank
3
1d: 0
1w: 0
1m: -
Key Stats
Market Cap
$159.07BUSD
Enterprise Value
$164.26BUSD
Revenue (TTM)
$45.13BUSD
EBITDA (TTM)
$12.15BUSD
Net Income (TTM)
$6.25BUSD
EBITDA Margin
27%
Profit Margin
14%
PE Ratio
25.6
Forward PE
16.3
PS Ratio
3.5
PB Ratio
3.0
EV/EBITDA
13.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Robert Ford open_in_new
Employees
115,000
Founded
1888
Website
abbott.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.7% -0.4% -12% -14% -28% -29%

News

Loading...

ABT Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
ABT
ISIN: US0028241000
Shares Out.:
1.742B1 Shares Float: 1.73B2
TV:
SA:
YF:
ABT
GF:
NQ:
ABT
BA:
ABT
MS:
91.33 USD
London Stock Exchange
MIC: XLON
0Q15
ISIN: US0028241000
TV:
SA:
YF:
GF:
BA:
MS:
93.62 USD
Lima Stock Exchange
MIC: XLIM
ABT
ISIN: US0028241000
Shares Out.:
1.742B1 Shares Float: 1.73B2
TV:
SA:
YF:
GF:
BA:
ABT
MS:
131.60 USD
Show all 12 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. The company also provides cancer screening and diagnostic test products. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
8.9%
25.8
$160.73B
1%
56.7
DHR
$126.55B
-20%
34.7
SYK
$120.69B
-24%
38.3
$84.93B
-47%
24.5
MDLN
$57.01B
-64%
30.3
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
-36%
22.2
$96.34B
84.32B EUR
-39%
36.7
7741
$60.51B
9.83T JPY
-62%
40.0
$44.95B
39.34B EUR
-72%
18.7
ALC
$35.9B
28.99B CHF
-77%
37.9
$29.94B
203.66B CNY
-81%
26.0
chevron_leftBack